Text Size

Risk Factors of Porphyria Cutanea Tarda (PCT)

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00213772
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT.

Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.


Condition
Porphyria Cutanea Tarda

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: “Factors Associated With Porphyria Cutanea Tarda in Patients Infected With Hepatitis C Virus”

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University Hospital, Strasbourg, France:

Estimated Enrollment: 280
Study Start Date: May 1999
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Porphyria cutanea tarda /HCV negative Porphyria cutanea tarda/ HCV positive HCV positive HCV negative controls
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00213772

Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Bernard Cribier, MD Hopitaux Universitaires de Strasbourg
Principal Investigator: O. Chosidow, MD Hopital Pitié-Salpétrière / Paris
Principal Investigator: M. Bagot, MD Hopital Henri Mondor / CHU Créteil
Principal Investigator: J.P Lacour, MD Hopital de l'Archet / CHU Nice
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00213772     History of Changes
Other Study ID Numbers: 2030
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Keywords provided by University Hospital, Strasbourg, France:
Porphyria cutanea tarda
hepatitis C
hemochromatosis

Additional relevant MeSH terms:
Porphyrias
Porphyria, Erythropoietic
Porphyria Cutanea Tarda
Porphyrias, Hepatic
Metabolism, Inborn Errors
Genetic Diseases, Inborn
 Skin Diseases, Metabolic
Skin Diseases
Metabolic Diseases
Skin Diseases, Genetic
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on June 18, 2013